Found: 14
Select item for more details and to access through your institution.
Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0450-4
- By:
- Publication type:
- Article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 9, p. 2890, doi. 10.1245/s10434-019-07393-w
- By:
- Publication type:
- Article
Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB--III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. e2151, doi. 10.1002/onco.13914
- By:
- Publication type:
- Article
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.11200
- By:
- Publication type:
- Article
Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 529, doi. 10.3779/j.issn.1009-3419.2013.10.06
- By:
- Publication type:
- Article
A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory or Relapsed Small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 9, p. 470, doi. 10.3779/j.issn.1009-3419.2013.09.06
- By:
- Publication type:
- Article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two‐center study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 6, p. 1431, doi. 10.1111/1759-7714.13088
- By:
- Publication type:
- Article
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study.
- Published in:
- Thoracic Cancer, 2013, v. 4, n. 2, p. 109, doi. 10.1111/j.1759-7714.2012.00152.x
- By:
- Publication type:
- Article
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5879, doi. 10.3390/cancers14235879
- By:
- Publication type:
- Article
Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 763, doi. 10.2147/OTT.S118982
- By:
- Publication type:
- Article
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
- Published in:
- Cancer Science, 2017, v. 108, n. 4, p. 590, doi. 10.1111/cas.13197
- By:
- Publication type:
- Article